Clinical Trial Update: Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens [Phase 2]

View source ↗

Summary

An update on an active-not-recruiting Phase II trial evaluating the combination of bazedoxifene and conjugated estrogens for breast cancer risk reduction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bazedoxifene (bazedoxifene)
• Conjugated Estrogens (ESTROGENS, CONJUGATED)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Risk Reduction, Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING